Trial Profile
Multicenter PhaseII study of Combination FOLFIRI with Erbitux in advanced/metastatic colorectal cancer: EGFR positive and KRAS wild type.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan
- 29 Jun 2009 New trial record